Concentrated Small-Cap Growth

Objective

Realize a total return exceeding the Russell 2000 Growth Index over a full market cycle.

Investment Strategy

The Oberweis Concentrated Small-Cap Growth strategy captures and highlights our domestic investment team's stock selection skill over a full market cycle by investing in the 25–45 highest conviction ideas from our two domestic smaller-cap growth strategies. The Concentrated Small-Cap Growth strategy generally invests in companies with market capitalization between $400 million and $5 billion at the time of purchase.

Benefits

  • Exposure to our team's 25 - 45 highest conviction ideas
  • Potential for significant alpha over a full market cycle
  • Emphasizes rapidly growing smaller-cap companies in the most dynamic phase of their development
  • Disciplined and repeatable investment process managed by a passionate and experienced investment team
  • Fully invested portfolio - no market timing

Lead Portfolio Manager(s)


Second Quarter 2019 Commentary

Strategy Basics

Inception Date:
Assets in Strategy:
Performance Benchmark:
Portfolio Status:
Minimum Account Size:
5/1/2002
$117.4 million (As of 6/30/19)
Russell 2000® Growth Index
Strategy open to new investors
$1 million for institutional account management

Our Process

Our process rests on our firmwide commitment to uncovering and capitalizing on the persistent and recurring stock pricing inefficiencies in small-, mid-cap, and emerging-growth equities caused by a lag in investor response to new information. This lag in recognizing the catalysts likely to positively impact future earnings growth drives the security selection across all our strategies and mutual funds. The criteria used within each product, however, can differ. This is how our investment team implements our philosophy in the Concentrated Small-Cap Growth strategy.

For the Quarter Ended

See pricing for all funds

Performance

Calendar Years

Downloadable .xls Composite Returns on the Concentrated Small-Cap Growth Strategy

Downloadable pdf. GIPS® Compliant Annual Disclosure Presentation for the Concentrated Small-Cap Growth Strategy

*OAM Concentrated Small-Cap Growth composite inception date: 5/1/02. From inception to December 31, 2010, the composite’s name was Concentrated Smid-Cap Growth.

The Russell 2000 Index measures the performance of approximately 2,000 companies with small market capitalizations. The Russell 2000 Growth Index measures the performance of those Russell 2000 companies with higher price-to-book ratios and higher forecasted earnings growth rates. Each index is an unmanaged group of stocks, whose performance does not reflect the deduction of fees, expenses, or taxes. You cannot invest directly in these indexes.

Advisory fees are disclosed in Part II of Form ADV. Performance is historical and includes the reinvestment of dividends and other income. Performance is calculated and presented in U.S. dollars. Past performance is not necessarily indicative of future results.

Oberweis Asset Management, Inc. (OAM) claims compliance with the Global Investment Performance Standards (GIPS® standards). To receive a complete list and description of Oberweis’ composites and/or a presentation that adheres to the GIPS® standards, contact Laura Dombro at 800-323-6166; write Oberweis Asset Management, Inc., 3333 Warrenville Road, Suite 500, Lisle, IL 60532; or e-mail laura.dombro@oberweis.net.

For the Quarter Ended

OAM Concentrated Small-Cap Growth
Number of Stocks
Weighted Market Capitalization (millions)
Median Market Capitalization (millions)
P/E Forward 4 Quarters (estimated)
P/E Trailing 4 Quarters
Long-Term Future EPS Growth Rate (estimated)
2019 P/E to Growth Rate Ratio
2020 P/E to Growth Rate Ratio (estimated)
Dividend Yield
Price-to-Book Ratio
Price-to-Cash Flow Ratio
Price-to-Sales Ratio
Long-Term Debt to Total Equity
Return on Equity
Net Profit Margin
Cash Position
Portfolio Turnover (2018)

Source: Eikon

SECTOR ALLOCATION as of

Top 10 Holdings as a % of Total Net Assets Portfolio Holdings are subject to change at any time. References to specific securities should not be construed as a recommendation to buy or sell and should not be assumed profitable.

Top 10 Holdings as of

Source: Eikon

Invest Now